SCHAUMBURG, Ill., Jan. 30 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company with a focus on injectableproducts, today announced that Ronald E. Pauli, chief financial officer, willpresent at the Merrill Lynch Global Pharmaceutical, Biotechnology and MedicalDevice Conference on Tuesday, February 5, 2008, at 11 a.m. EST. The conferencewill be held February 5-7, 2008 at the Grand Hyatt Hotel in New York.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, founded in 2006, is a privately held specialtypharmaceutical company focused on developing, manufacturing, sourcing andmarketing pharmaceutical products, with a specific focus on injectableproducts. Sagent has created a unique, global network of resources, comprisedof rapid development capabilities, sophisticated manufacturing and innovativedrug-delivery technologies, quickly yielding an extensive portfolio ofpharmaceutical products that fulfills the evolving needs of patients. Sagentcurrently has more than 200 products in development.
For more information about Sagent, please visithttp://www.sagentpharma.com.
SOURCE Sagent Pharmaceuticals, Inc.